Table 5.
Samples | Anti‐lipase | Anti‐α‐glucosidase | Anti‐α‐amylase | Reference |
---|---|---|---|---|
Powder | ||||
IC50 (μg mL−1) | IC50 (μg mL−1) | IC50 (μg mL−1) | ||
GDPC1 | 32.37 ± 1.41ns | 61.31 ± 1.43**** | 74.88 ± 1.80**** | 38 |
GDPC2 | 39.57 ± 1.87ns | 43.85 ± 1.31*** | 55.49 ± 1.61*** | 38 |
GDPBIO | 34.48 ± 1.96ns | 78.76 ± 1.97**** | 68.09 ± 1.57**** | 38 |
Positive controls | 37.42 ± 1.05 | 35.51 ± 0.94 | 50.12 ± 1.37 |
Data are expressed as means ± SD (n = 3). Acarbose was used as a positive control in the α‐amylase and α‐glucosidase tests. Orlistat was used as a positive control in the lipase test. Differences within and between groups were evaluated by one‐way ANOVA followed by a multicomparison Dunnett's test: ****P < 0.0001, ***P < 0.001, compared with acarbose in α‐glucosidase and α‐amylase, and Orlistat in a lipase inhibition assay (IC50 = μg mL−1).